A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, nervous system disorder, phenylketonuria	Recruiting	Not stated	2026-03-24		NCT06305234

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BioMarin Pharmaceutical	32

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Boston Children's Hospital	Boston	United States	20
Children's Wisconsin/Medical College of Wisconsin	Milwaukee	United States	3
Emory University	Atlanta	United States	262
Northwestern University	Chicago	United States	727
Oregon Health & Science University	Portland	United States	261
Riley Children's Hospital/ Indiana University Health	Indianapolis	United States	1
Tulane University School of Medicine	New Orleans	United States	47
University of Colorado	Aurora	United States	147
University of Pittsburgh Medical Center	Pittsburgh	United States	127
UT Southwestern Medical Center	Dallas	United States	210
Vanderbilt University Medical School	Nashville	United States	2